Additional file 2 of Aberrant activation of five embryonic stem cell-specific genes robustly predicts a high risk of relapse in breast cancers

Additional file 2: Table S1. List of genes with predominant expression in testis, placenta and/or embryonic stem cells. Table S2. Frequencies of ectopic activations of the tissue-specific genes. Table S3. Results of the validation step in the biomarker discovery pipeline. Table S4. Datasets of normal tissues and breast cancers with corresponding sample sizes. Table S5. List of normal tissues and the corresponding sample sizes.